<DOC>
	<DOCNO>NCT00259831</DOCNO>
	<brief_summary>The purpose Study determine prophylactic effect CVT-E002 treatment upper respiratory tract infection healthy adult employee work resident continue care facility . It hypothesize use CVT-E002 effectively reduce incidence , severity duration upper respiratory infection among participant compare placebo .</brief_summary>
	<brief_title>Efficacy Cold-FX ( CVT-E002 ) Prevention Upper Respiratory Tract Infections Healthy Adults</brief_title>
	<detailed_description>Eligible continue care employee randomly assign either treatment placebo group equal number group . The treatment consist take two capsule CVT-E002 ( 400mg ) placebo every morning , breakfast , period 12 week . The subject give assessment form log specific symptom daily basis get cold . Symptoms include sore throat , runny nose , nasal congestion , hoarseness , cough , earache , fever . Subjects require maintain dose even upper respiratory infection request take additional medication upper respiratory infection unless prescribe family physician .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Respiratory Tract Infections</mesh_term>
	<criteria>age 1864 year pregnant breast feed good general health medical condition : HIV infection ; malignancy ; cardiovascular disease ; hypertension ; renal , pulmonary hepatic abnormality ; neurologic psychiatric disease ; tuberculosis ; multiple sclerosis ; recent acute respiratory infection ( &lt; 2 week ) medication : warfarin ; immunosuppressive therapy ; corticosteroid ; phenalzine ; pentobarbital ; haloperidol major surgical procedure previous six month history alcohol/drug abuse pregnancy lactation woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>cold</keyword>
	<keyword>influenza</keyword>
</DOC>